Skip to main content
. 2018 Jun 6;9:540. doi: 10.3389/fphar.2018.00540

FIGURE 1.

FIGURE 1

Puerarin protected against abdominal aortic banding (AB)-induced cardiac fibrosis. (A) Gross hearts. (B) HE staining. (C) Heart weight/body weight (HW/BW) ratio and heart weight/tibial length (HW/TL) ratio. (D) Representative echocardiographic images. (E) Left ventricular function. (F) Indexes of cardiac structure. (G) Masson trichrome staining and immunohistochemical staining of collagen I and III. (H) Collagen volume fraction (CVF) of Masson trichrome staining. (I) Quantitative analysis of collagen I and collagen III in vivo. Sham, sham-operated group; AB, aortic banding group; Pue, puerarin-treated aortic banding group. P < 0.05 vs. Sham, ∗∗P < 0.01 vs. Sham, #P < 0.05 vs. AB, ##P < 0.01 vs. AB. n = 6 for each group.